ALFA Finder| Value | ₹237.5 Cr |
|---|
BSE filing, NSE: BAJAJHCARE. Summary written from the filing by ALFA Finder's alert engine.
Bajaj Healthcare Ltd: key numbers
- Share price
- ₹325.35
- Market cap
- ₹1,095 Cr
- Revenue (annual)
- ₹611.0 Cr
- Net profit (annual)
- ₹15.77 Cr
- P/E (TTM)
- 53.1×Sector 43.8×
- Promoter holding
- 58.59%+0.00% QoQ
- FII holding
- 2.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bajaj Healthcare Ltd
All →Bajaj Healthcare Earnings Call Transcript: Key Takeaways
Bajaj Healthcare delivered strong H1 growth led by a 82% surge in formulations and key new specialty launches.
- Call
- Guides 15% growth
Bajaj Healthcare Results Update
Bajaj Healthcare reported Q2 FY27 revenue of ₹175.9 Crore, up 18.9% YoY. EBITDA stood at ₹32.1 Crore, reflecting a 12.2% YoY increase.
Bajaj Healthcare Other Announcement
Bajaj Healthcare filed its Monitoring Agency Report for the quarter ended September 30, 2026, as required by SEBI regulations for the utilization of preferential issue proceeds.
Bajaj Healthcare Q2 FY27 Results: Net Profit ₹14.1 Cr, Up 27.0% YoY
Bajaj Healthcare Ltd reported revenue from operations of ₹175.9 Cr (+18.9% YoY) and net profit of ₹14.1 Cr (+27.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹14.1 Cr · +27.0% YoY
Bajaj Healthcare Acquisition
Bajaj Healthcare received NCLT approval to acquire Genrx Pharmaceuticals Private Limited as a going concern. The entity will become a wholly owned subsidiary.
Bajaj Healthcare Merger & Restructuring Worth ₹14.67 Cr
Bajaj Healthcare Limited has executed a deed of assignment to sell its undertaking located in Dahej Industrial Area, Gujarat, for approximately Rs. 14.67 Crore.
- Value
- ₹14.67 Cr
Other debt & borrowing announcements
All →Poonawalla Fincorp Debt & Borrowing: ₹500 Cr
Poonawalla Fincorp allotted 50,000 secured NCDs totaling ₹500.005 Crore under Series H1 FY 26-27. The 5-year instruments carry 9.15% p.a. coupon with first-ranking security on hypothecated assets.
- Value
- ₹500.0 Cr
- Execution
- 5 years (1,826 days; maturity Nov 12, 2031)
Shriram Finance Debt & Borrowing: ₹0.35 Cr
Shriram Finance Ltd paid Rs.0.35 Crore of monthly interest on its NCD8 Tranche 1 debentures on 12 November 2026. The payment was made on the due date, with no change in the payment frequency.
- Value
- ₹0.35 Cr
Muthoot Capital Services Debt & Borrowing: ₹0.65 Cr
Muthoot Capital Services confirmed monthly interest payment of ₹0.65 Crore on NCDs for October 2026. This is a routine Regulation 57(1) debt-servicing certificate.
- Value
- ₹0.65 Cr
- Execution
- Monthly
Mufin Green Finance Debt & Borrowing: ₹0.85 Cr
Mufin Green Finance paid Rs.0.85 Crore interest on its Rs.100 Crore secured NCDs on November 11, 2026. The payment confirms timely servicing of listed debt.
- Value
- ₹0.85 Cr
HDFC Life Insurance Company Debt & Borrowing
HDFC Life intimated a CRC meeting on November 16, 2026, to approve commercial terms for up to ₹500 Crore of unsecured subordinated NCDs. The filing only schedules the meeting; no terms are yet approved.
Repco Home Finance Debt & Borrowing
Repco Home Finance submitted a revised Security Cover and Covenant Compliance Certificate as of 30 September 2026, extending compliance coverage to all Debenture Trust Deed covenants. The revision follows the earlier certificate and only changes the covenant scope and UDIN.